Rivermark Medical, a urology-focused medical device company committed to redefining benign prostatic hyperplasia (BPH) ...

Presentations underscore long-term clinical outcomes, safety and durability in BPH treatment Attendees invited to experience hands-on HYDROS Robotic System demonstrations SAN JOSE, Calif., April 24, ...

The Food and Drug Administration (FDA) is reviewing an ER formulation of alfuzosin hydrochloride 10 mg for once-daily administration for treatment of symptomatic BPH. The IR and twice-daily ER ...

The new option, which was announced by the Okanagan Health Surgical Centre and Kelowna Urology is called Rezūm Water Vapor ...

Of the agents that interfere with testosterone's stimulatory effect on prostate size, finasteride, a 5-α-reductase inhibitor, is the only one with FDA-approved labeling for BPH treatment.

Men who suffer from benign prostatic hyperplasia can return to regular activities within a few days after the Holmium Laser Enucleation of the Prostate (HoLEP). Related Rivers, Benue, other states ...

Prostate enlargement is an abnormal enlargement of the prostate gland causing variable degrees of bladder outlet obstruction.

Prescription drugs may also be an option for men with BPH. Types of drugs include: Alpha blockers are pills used to relax the muscles of the prostate and bladder to reduce BPH symptoms. They do not ...

Dr Christopher Kelly discusses the evolution of patient outcomes with different benign prostatic hyperplasia (BPH) treatments, particularly focusing on ejaculation preservation and durability. Dr ...